Ignite Creation Date:
2024-05-05 @ 11:30 AM
Last Modification Date:
2024-10-26 @ 9:09 AM
Study NCT ID:
NCT00066443
Status:
COMPLETED
Last Update Posted:
2023-08-04
First Post:
2003-08-06
Brief Title:
Epirubicin Docetaxel and Pegfilgrastim in Treating Women With Locally Advanced or Inflammatory Breast Cancer
Sponsor:
NCIC Clinical Trials Group
Organization:
Canadian Cancer Trials Group